Ficlatuzumab, Cisplatin and IMRT in Locally Advanced Head and Neck Squamous Cell Carcinoma

NCT02277184 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

1

Enrollment

OTHER

Sponsor class

Stopped the investigator left the institution

Conditions

Carcinoma, Squamous Cell of Head and Neck

Interventions

DRUG: Ficlatuzumab
DRUG: Cisplatin
RADIATION: Intensity Modulated Radiotherapy (IMRT)

Sponsor

Julie E. Bauman, MD, MPH

Collaborators

[object Object]